Set for multiple late-stage readouts in oncology in 2026, BioNTech is entering a crucial phase of its roadmap beyond Covid-19 vaccines.

BioNTech has initiated a Phase III clinical trial for its oncology candidate BNT324 in metastatic castration-resistant prostate cancer, aiming to compare the drug against current standard chemotherapy ...

The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine. "We feel that a cure for cancer or to changing cancer patients' ...

BERLIN, Jan 1 (Reuters) - BioNTech (22UAy.DE), opens new tab is working flat out with partner Pfizer (PFE.N), opens new tab to boost production of their COVID-19 vaccine, its founders said, warning ...

Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...

German biotech BioNTech today announced that the US Food and Drug Administration (FDA) has granted fast track designation to ...

Pfizer and BioNTech announced Monday their coronavirus vaccine was more than 90% effective in preventing COVID-19 among those without evidence of prior infection, hailing the development as “a great ...

Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID vaccines.

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

TAIPEI (Reuters) -Taiwan's Foxconn and TSMC said on Monday they had reached deals to buy 10 million doses of Germany's BioNTech SE's COVID-19 vaccine, putting the total cost of the highly politicised ...

Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.